Novartis OTC Division Is “Fastest Growing” Among Industry Leaders – CEO
This article was originally published in The Tan Sheet
Executive Summary
Novartis Consumer Health showed "strong performance" in 2006 with full year net sales of $7.53 billion, according to earnings results announced during a fourth-quarter and year-end call Jan. 18
You may also be interested in...
Novartis Cough/Cold OTCs Boost Consumer Health Division In Q1
Novartis' over-the-counter sales achieved double-digit growth in its first quarter on the strength of cough and cold brands and expansion into new markets, particularly Japan, the company said
Novartis Cough/Cold OTCs Boost Consumer Health Division In Q1
Novartis' over-the-counter sales achieved double-digit growth in its first quarter on the strength of cough and cold brands and expansion into new markets, particularly Japan, the company said
Novartis Cough/Cold OTCs Boost Consumer Health Division In Q1
Novartis' over-the-counter sales achieved double-digit growth in its first quarter on the strength of cough and cold brands and expansion into new markets, particularly Japan, the company said